Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
The aims of this work were to investigate the possible effect of several antimicrobial agents alone and in combinations against 190 clinical isolates of Mycobacterium tuberculosis and 30 isolates of Mycobacterium avium, 30 Mycobacterium fortuitum and 30 Mycobacterium chelonei. The susceptibility was determined in Müller-Hinton agar and Middlebrook 7H 10 agar. For interpretation of the results the minimum inhibitory concentration (MIC) was determined and for the combinations of antimicrobials we used the Fractional Inhibitory Concentration Index (FIC). The possible clinical efficacy was determined by the Inhibitory Quotient. The synergistic effect of several combinations of these compounds was demonstrated.
Casal
M
M
Department of Medical Microbiology, Faculty of Medicine, University of Córdoba, Spain.
Rodríguez
F
F
Gutierrez
J
J
Ruiz
P
P
Benavente
M C
MC
Villalba
R
R
Moreno
G
G
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000188:drug therapy; D009162:Mycobacterium avium / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009170:Nontuberculous Mycobacteria / Q000187:drug effects; D014376:Tuberculosis / Q000188:drug therapy
D000900:Anti-Bacterial Agents